Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis

• Autores: Rohan Khera, Mohammad Hassan Murad, Apoorva Krishna Chandar
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 315, Nº. 22, 2016, págs. 2424-2434
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • This network meta-analysis compares weight loss and adverse events with available drug treatments for obesity, including liraglutide, naltrexone-bupropion, and lorcaserin.